Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

IQPC_London2

IQPC_London2

Episodes
15
Followers
Listens
8881
×  

Follow This Show

Stay in the know about new episodes and updates.
IQPC Pre-Event Interviews

On-Demand Episodes

Catherine McElhany, Manager of Planning & Performance, Gulf Coast Restoration, BP talks about some of the ways of implementing Process Excellence into the business model. She discusses how BP is working to retain... more

Jeremy Williams, Head of Pension Risk at the Daily Mail and General Trust (DMGT) Pensions Office, talks about De-risking Longevity in the European context. He begins by discussing how the financial crisis has changed the... more

Robert Amaee, Head of the Corruption at the Serious Fraud Office (SFO), begins the interview by giving an overview of the SFO’s current focus on corruption enforcement and its approach to enforcing the new Bribery Act. He then reflects... more

We talk to ESG specialist, Marcel Jeucken, Head of Responsible Investing at PGGM and author of Sustainable Banking and Finance: People-The Financial Sector and the Future of the Planet. PGGM started looking at socially... more

Pharma IQ speaks to Andrew Marr, Director of e-Regulatory Development and Global Regulatory Operations and Co-Chair of the PIM Steering Committee on behalf of the EFPIA. This interview addresses the latest developments in Project... more

This podcast series aims to provide a sneak preview into some of the issues to be discussed at the Customer Experience Exchange – This first edition will look specifically at Customer Experience and Outbound Contact. We interview Morris... more

Associate Professor Nair Rodriguez-Hornedo of the University of Michigan discusses the latest successful strategies in making co-crystals, providing firsthand examples from the University's Department of Pharmaceutical... more

Dr Dave Miller, Senior Principal Scientist at Hoffmann La Roche, shares his views on how to optimise amorphous form selection, techniques to enhance amorphous drug performance and the best strategies to stabilise amorphous forms. He also... more

Find out more about the challenges in pre- and post-release stability testing and formulation. This interview explores the technologies being employed by Lifecycle Pharma to pre-empt these. Claire Willsher, head of analytical development at... more

Learn firsthand about deployment of ELNs within the biopharmaceutical area - this interview with Ralph Haffner, head of biologic research informatics at Roche, documents the drivers, the planning and selection phase, through to the... more

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled